Zevra’s Leading Drug Candidate for Idiopathic Hypersomnia Treatment Advancing
The company also announced plans to begin a search for a new CEO to succeed Richard W. Pascoe, who will retire on June 1.
Read More
Author: Alyx Arnett
Apnimed to Present Data on Investigational Oral Treatment for Sleep Apnea
Data from the phase 2b trial of Apnimed’s leading drug candidate for OSA will be featured at The American Thoracic Society’s ATS 2023 International Conference in Washington, DC.
Read More
AASM Unveils 2023 Award Recipients
Five individuals have been selected as the 2023 American Academy of Sleep Medicine award recipients for their contributions to the field of sleep medicine.
Read More
Sleep Research Society Announces 2023 Award Recipients
The Sleep Research Society has selected four sleep and circadian scientists as recipients of the 2023 Sleep Research Society awards, which recognize excellence in sleep and circadian research.
Read More
FDA Updates Warnings for Class of Drugs Used to Treat Narcolepsy
The FDA says current prescribing information for some prescription stimulants does not provide up-to-date warnings about the harms of misuse and abuse.
Read More